Ethosuximide
اتوسوکسیماید
🧠 Nervous SystemSuccinimide anticonvulsant
Market / country: 🇺🇸 USA
Zarontin (US)
🧮 Dose calculator
Absence epilepsy (petit mal) · Regimen source: FDA Ethosuximide soln · Dosage and Administration
- • Increase by 250 mg/day every 4–7 days until controlled. Optimal for most children 20 mg/kg/day. Above 1.5 g/day (divided) only under strict supervision. FDA Ethosuximide soln · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to succinimides. FDA Ethosuximide soln · Contraindications
Warnings
- • Blood dyscrasias (sometimes fatal) and immune thrombocytopenia; periodic blood counts. FDA Ethosuximide soln · Warnings
Formulations
- 250 mg / 5 mL oral solution — solution 🇺🇸 USA FDA Ethosuximide soln · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ethosuximide soln · Pregnancy
“To provide information regarding the effects of in utero exposure to ethosuximide, physicians are advised to recommend that pregnant patients taking ethosuximide enroll in the (NAAED) Pregnancy Registry.”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ethosuximide soln · Pediatric Use
“Safety and effectiveness in pediatric patients below the age of 3 years have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA080258
- DailyMed (FDA label)FDA Ethosuximide soln
- MedlinePlus (NIH)Ethosuximide
- WHO ATC/DDDN03AD01
- Darooyab (Iran)Ethosuximide
🇮🇷 Registered in Iran Darooyab · G-663/Ethosuximide
Dosage forms with Iranian generic codes, per Darooyab.
- 07651 · ETHOSUXIMIDE 100MG CAP · کپسول اتوسوکسیماید ۱۰۰ میلیگرم
- 00514 · ETHOSUXIMIDE 250MG CAP · کپسول اتوسوکسیماید ۲۵۰ میلیگرم
- 00513 · ETHOSUXIMIDE 250MG/5ML 240ML SYRUP · شربت اتوسوکسیماید ۲۵۰ میلیگرم / ۵ میلیلیتر ۲۴۰ میلیلیتر
- 52620 · ETHOSUXIMIDE SYRUP ORAL 250 mg/5mL 200 mL · شربت اتوسوکسیماید ۲۵۰ میلیگرم / ۵ میلیلیتر ۲۰۰ میلیلیتر
- 52957 · ETHOSUXIMIDE SYRUP ORAL 250 mg/5mL 100 mL · شربت اتوسوکسیماید ۲۵۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Ethosuximide soln · How SuppliedFDA Ethosuximide soln · Dosage and AdministrationFDA Ethosuximide soln · ContraindicationsFDA Ethosuximide soln · WarningsFDA Ethosuximide soln · SPL approval / marketing categoryFDA Ethosuximide soln · PregnancyFDA Ethosuximide soln · Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-663/Ethosuximide
- Clinical review⚠ Unverified